Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

Shares of DexCom Inc. rallied 3.79% to $73.38 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.08% to 5,675.29 and the Dow ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

(NASDAQ:DXCM) stands against the other IoT stocks ... our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter ...

Hence, I have issued a sell rating on the stock. DXCM came up with its 4Q24 results earlier last month. The results were quite muted but were an improvement over even worse results in 3Q24.

While the company's stock has faced significant pressure following a disappointing second quarter in 2024, analysts remain cautiously optimistic about its future prospects, supported by DexCom's ...

While the company's stock has faced significant pressure following a disappointing second quarter in 2024, analysts remain cautiously optimistic about its future prospects, supported by DexCom's GREAT ...